Drugs · acquisition-cost intelligence
Xanax
alprazolam· ingredient alprazolam· ALPRAZOLAM 1 mg/1; ALPRAZOLAM .25 mg/1; ALPRAZOLAM 2 mg/1; ALPRAZOLAM .5 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$7.03
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 4 weeks.
2026-01-012026-05-20
Same-ingredient options by acquisition cost
Other alprazolam products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| alprazolam | $0.02340 | −$7.00 |
| alprazolam | $0.02430 | −$7.00 |
| Alprazolam Extended Release | $0.19621 | −$6.83 |
| alprazolam | $1.17 | −$5.86 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.